CSNpharm
BMS-309403 is an inhibitor of fatty acid binding protein 4 (FABP4) with Ki of less than 2 nM that decreases fatty acid uptake in adipocytes in vitro.
More Information
Supplier Page
CSNpharm
BMS-309403 is an inhibitor of fatty acid binding protein 4 (FABP4) with Ki of less than 2 nM that decreases fatty acid uptake in adipocytes in vitro.
More Information
Supplier Page
BMS-5
5mg
| ≥99%
CSNpharm
BMS-5 is a highly selective and potent inhibitor of both LIMK 1 and 2 with IC50 values of 7 and 8 nM, respectively.
More Information
Supplier Page
BMS-5
100mg
| ≥99%
CSNpharm
BMS-5 is a highly selective and potent inhibitor of both LIMK 1 and 2 with IC50 values of 7 and 8 nM, respectively.
More Information
Supplier Page
BMS-5
50mg
| ≥99%
CSNpharm
BMS-5 is a highly selective and potent inhibitor of both LIMK 1 and 2 with IC50 values of 7 and 8 nM, respectively.
More Information
Supplier Page
BMS-5
10mg
| ≥99%
CSNpharm
BMS-5 is a highly selective and potent inhibitor of both LIMK 1 and 2 with IC50 values of 7 and 8 nM, respectively.
More Information
Supplier Page
BMS-5
1mg
| ≥99%
CSNpharm
BMS-5 is a highly selective and potent inhibitor of both LIMK 1 and 2 with IC50 values of 7 and 8 nM, respectively.
More Information
Supplier Page
CSNpharm
BMY 7378 2HCl is a 5-HT1A partial agonist and a high-affinity α1D adrenoceptor antagonist with Ki values of 2, 800 and 600 nM for cloned rat α1D, rat α1A and hamster α1B receptors respectively.
More Information
Supplier Page
CSNpharm
BMY 7378 2HCl is a 5-HT1A partial agonist and a high-affinity α1D adrenoceptor antagonist with Ki values of 2, 800 and 600 nM for cloned rat α1D, rat α1A and hamster α1B receptors respectively.
More Information
Supplier Page
CSNpharm
BMY 7378 2HCl is a 5-HT1A partial agonist and a high-affinity α1D adrenoceptor antagonist with Ki values of 2, 800 and 600 nM for cloned rat α1D, rat α1A and hamster α1B receptors respectively.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
Boc-NH-ethyl-SS-propionic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
More Information
Supplier Page
CSNpharm
Boc-NH-ethyl-SS-propionic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
More Information
Supplier Page
CSNpharm
Boc-NH-PEG1-CH2CH2COOH is a cleavable (1 unit PEG) ADC linker and also a PEG- and Alkyl/ether-based PROTAC linker can be used in the synthesis of antibody-drug conjugates (ADCs) or PROTACs.
More Information
Supplier Page
CSNpharm
Boc-NH-PEG4-CH2CH2COOH is a PEG-based PROTAC linker can be used in the synthesis of PROTAC. Boc-NH-PEG4-CH2CH2COOH is also a cleavable ADC linker used as a linker for antibody-drug conjugates (ADC).
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
Linker for Antibody-Drug-Conjugation (ADC). The Val-Cit will specifically be cleaved by catepsin B. As this enzyme is only present in the lysosome the ADC payload will be release only in the cell.
More Information
Supplier Page
CSNpharm
Linker for Antibody-Drug-Conjugation (ADC). The Val-Cit will specifically be cleaved by catepsin B. As this enzyme is only present in the lysosome the ADC payload will be release only in the cell.
More Information
Supplier Page
CSNpharm
Linker for Antibody-Drug-Conjugation (ADC). The Val-Cit will specifically be cleaved by catepsin B. As this enzyme is only present in the lysosome the ADC payload will be release only in the cell.
More Information
Supplier Page
CSNpharm
Linker for Antibody-Drug-Conjugation (ADC). The Val-Cit will specifically be cleaved by catepsin B. As this enzyme is only present in the lysosome the ADC payload will be release only in the cell.
More Information
Supplier Page
CSNpharm
Bombesin, a tetradecapeptide originally isolated from frog skin, has an important role in the release of gastrin and the activation of G-protein receptors.
More Information
Supplier Page
CSNpharm
Bombesin, a tetradecapeptide originally isolated from frog skin, has an important role in the release of gastrin and the activation of G-protein receptors.
More Information
Supplier Page
CSNpharm
Bombesin, a tetradecapeptide originally isolated from frog skin, has an important role in the release of gastrin and the activation of G-protein receptors.
More Information
Supplier Page
CSNpharm
Bombesin, a tetradecapeptide originally isolated from frog skin, has an important role in the release of gastrin and the activation of G-protein receptors.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
BP897
25mg
| ≥99%
CSNpharm
BP897 is a partially selective dopamine D3 receptor agonist (Ki = 0.92 nM) that developed for the study of cocaine addiction.
More Information
Supplier Page
BP897
5mg
| ≥99%
CSNpharm
BP897 is a partially selective dopamine D3 receptor agonist (Ki = 0.92 nM) that developed for the study of cocaine addiction.
More Information
Supplier Page
BP897
10mg
| ≥99%
CSNpharm
BP897 is a partially selective dopamine D3 receptor agonist (Ki = 0.92 nM) that developed for the study of cocaine addiction.
More Information
Supplier Page
BP897
1mg
| ≥99%
CSNpharm
BP897 is a partially selective dopamine D3 receptor agonist (Ki = 0.92 nM) that developed for the study of cocaine addiction.
More Information
Supplier Page
BP897
50mg
| ≥99%
CSNpharm
BP897 is a partially selective dopamine D3 receptor agonist (Ki = 0.92 nM) that developed for the study of cocaine addiction.
More Information
Supplier Page
BP897
250mg
| ≥99%
CSNpharm
BP897 is a partially selective dopamine D3 receptor agonist (Ki = 0.92 nM) that developed for the study of cocaine addiction.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
BQR695
100mg
| ≥99%
CSNpharm
CSNpharm
CSNpharm
BRD9876 is a selective inhibitor of MM1S growth. It is selective for microtubule bound Eg5 and causes a rapid arrest in G2/M phase.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm